Holigos® IBS Restore Clinical Trial
Holigos® IBS Restore is a medical food for the dietary management of IBS. It has been shown in a clinical study of 317 participants to beneficially alter the gut microbiome. The objective of this trial was to determine whether administering once-daily Holigos® IBS Restore would relieve the symptoms of IBS.†
The trial demonstrated that Holigos® IBS Restore benefited all IBS subtypes across multiple endpoints:
In a clinical trial, over 86% of patients rated their IBS symptoms as IMPROVED.†
improvement in quality of life scores†
Patients with >50 point Improvement by week 4†
Holigos® IBS Restore was studied in a 12-week, multi-center, open-label trial in patients with IBS.
Patients completing the trial took Holigos® IBS Restore (5g) once daily for 12 weeks
Holigos® IBS Restore is a neutral powder that is provided in a carton box of 28 single-dose packets
Three hundred seventeen (317) IBS patients were supplied with Holigos® IBS Restore (intention-to-treat, ITT) and 273 patients completed the study.
Overall IBS Severity Score
Change in Bristol stool
Holigos® IBS Restore is safe and well-tolerated.
The ingredients in Holigos® are well tolerated by those suffering from IBS
Common side effects associated with Holigos® IBS Restore included mild local symptoms in the gut, such as abdominal pain, distension, and flatulence